Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.76
Delayed Data
As of 2:27pm ET
 -0.13 / -4.50%
Today’s Change
2.62
Today|||52-Week Range
9.37
-54.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
AssetsCash68.4M104.2M75.1M71.6M
 
 
 
 
 
Short Term Investment Cash37.3M35.9M-29.2M-3.5M
 
 
 
 
 
Cash & Short Term Investments118.6M205.5M188.6M175.1M
 
 
 
 
 
 
ReceivablesReceivables32.0M2.6M4.5M6.8M
 
 
 
 
 
 
InventoriesInventories754.0K1.2M1.4M4.9M
 
 
 
 
 
 
Current AssetsOther Current Assets1.8M2.0M1.8M2.6M
 
 
 
 
 
Current Assets153.2M211.3M196.4M189.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.7M2.9M2.9M2.9M
 
 
 
 
 
Depreciation-2.0M-2.1M-2.1M-2.2M
 
 
 
 
 
Other Assets426.0K621.0K612.0K882.0K
 
 
 
 
 
Total Assets154.5M213.0M198.0M191.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable4.7M4.2M2.5M6.6M
 
 
 
 
 
Accrued Expenses9.8M12.6M13.3M19.2M
 
 
 
 
 
Other Current Liabilities13.3M20.8M21.5M27.4M
 
 
 
 
 
Other Liabilities21.7M29.7M25.9M36.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt82.9M83.9M84.9M86.0M
 
 
 
 
 
Deferred Taxes0.00-547.0K-547.0K-547.0K
 
 
 
 
Other Liabilities378.0K354.0K305.0K258.0K
 
 
 
 
 
Total Liabilities137.6M190.6M185.7M195.4M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity16.9M22.3M12.3M-4.2M
 
 
 
 
 
Total Shareholder Equity16.9M22.3M12.3M-4.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding123.1M123.5M124.9M125.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.